Discover
HSDT
Solana Company
1.74
2 x 1.29
2 x 2.16
bid
ask
+
0.09
5.45%
2 @ 07:30 AM
1.80 +0.06 (3.52%)
| Ytd | -39.79% | |
| 1y | -79.77% |
1.66
day range
1.80
1.19
52 week range
25.50
| Open | 1.68 | Prev Close | 1.65 | Low | 1.66 | High | 1.80 | Mkt Cap | 101.59M |
| Vol | 339.75K | Avg Vol | 343.24K | EPS | 379.14 | P/E | 0.00 | Forward P/E | -0.40 |
| Beta | 1.61 | Short Ratio | 0.34 | Inst. Own | 5.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 1.90 | 200-d Avg | 4.53 | 1yr Est | 4.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-12 | 2024-09 | 0 | -0.99 | N/A | N/A |
| 2024-08-12 | 2024-06 | 0 | -0.64 | N/A | N/A |
| 2024-05-13 | 2024-03 | 0 | -3.08 | N/A | N/A |
| 2024-03-28 | 2023-12 | -4.05 | -1.47 | 2.58 | 63.70% |
| 2023-11-09 | 2023-09 | 0 | -5.49 | N/A | N/A |
| 2023-08-10 | 2023-06 | -5.5 | -3 | 2.5 | 45.45% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-03-05 | Roth MKM | Upgrade | Buy | Buy |
Profile
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-12-13 | ANDREEFF DANE C | Chief Executive Officer | 0.00 | Purchase |
| 2023-05-23 | BUCKMAN PAUL R | Director | 89.82K | Stock Award(Grant) |
| 2023-05-23 | PERKINS SHERRIE L. | Director | 90.04K | Stock Award(Grant) |
| 2023-05-23 | STRAW EDWARD M. | Director | 90.11K | Stock Award(Grant) |
| 2023-05-23 | WALTER BLANE | Director | 93.45K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Susquehanna International Group, LLP | 18.22K | 17.49K | 0.49% |
| 2024-09-29 | Geode Capital Management, LLC | 17.75K | 17.04K | 0.48% |
| 2024-09-29 | Two Sigma Securities, LLC | 14.24K | 13.67K | 0.38% |
| 2024-09-29 | Vanguard Group Inc | 12.60K | 12.09K | 0.34% |
| 2024-09-29 | UBS Group AG | 12.76K | 12.25K | 0.34% |
| 2024-09-29 | Tower Research Capital LLC (TRC) | 4.79K | 4.60K | 0.13% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Extended Market Index Fund | 16.64K | 15.97K | 0.45% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 12.60K | 12.09K | 0.34% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 4.53K | 4.35K | 0.12% |
Split
| Split | Date |
|---|---|
| 1 : 50 | 2025-07-01 |
| 1 : 15 | 2025-05-02 |
| 1 : 50 | 2023-08-17 |
| 1 : 35 | 2021-01-04 |
| 1 : 5 | 2018-01-23 |